The short answer
Hims and Hers is our top pick for fastest time to first prescription. Score 7.4 of 10. Median intake to script ready under 24 hours, async clinician review with no scheduled-visit gap, and the cleanest fast-onboarding flow in our chart. Best fit if you've taken GLP-1 before or know your tolerance.
What to know first
Time to first prescription is the metric most patients underweight at sign-up and overweight by week two when they're still waiting on a script. The fast-onboarding category breaks into two camps: async-review programs that process intake in 24 hours via a clinician sign-off without a live visit (Hims, Eden, Ro), and synchronous programs that book same-day video PCP visits (PlushCare). Async wins on raw speed for healthy patients; synchronous wins for patients who want to talk to a clinician before paying. The wrong fast-onboarding program is one whose speed comes from skipping contraindication screening; the right one is fast because of operational efficiency, not clinical shortcuts.
What we considered
- Median time from intake start to first prescription ready (hours)
- Async review available (no scheduled-visit gap)
- Clinical screening for contraindications (speed not at the cost of safety)
- Speed extends to refills and dose changes
- Clear about who fast onboarding is appropriate for
Some visit links earn us a commission.
Scores out of 10, equal-weighted across five dimensions. How we score
Top pick: Hims & Hers
Hims's 24-hour median intake-to-script, async review with proper contraindication screening and predictable cash-pay maintenance pricing make it the cleanest fastest-start pick. PlushCare wins if you want a same-day live PCP visit instead of async.
Read the full Hims & Hers review →
Why Hims & Hers won this category
Hims's async intake model is the fastest in our chart from sign-up to prescription ready. The median patient completes intake in under 30 minutes and has a clinician sign-off within 24 hours. No scheduled video visit, no waiting for a calendar opening. The intake is mobile-friendly, which matters because most first-decision GLP-1 patients shop on their phone.
The operational efficiency is real, not corner-cutting. Hims's intake includes contraindication screening (thyroid history, MEN-2, pancreatitis), medication interaction checks and a clinician review before the script ships. They skip the synchronous visit, not the clinical review. The trade-off is that complex medical histories don't get the same depth as a live visit; healthy patients without major comorbidities are the right fit.
The pricing structure holds at speed. Hims's starter pricing is genuinely low ($39 at the lowest tier) but the maintenance-dose cash-pay path runs $199 to $399 monthly depending on the compounded or branded route. This is the second-cheapest predictable cash-pay maintenance path in our chart after Mochi and Henry. Other fast-onboarding programs trade speed for higher long-run pricing; Hims doesn't.
Cancellation is clean (with one caveat). Month-to-month online cancel, no commitment, no prepay. The caveat is that member feedback consistently flags the cancellation flow as friction-heavy with retention upsells. The cancel itself works; the path to the cancel button has multiple retention prompts. We score this in the cancellation dimension; cleaner picks for cancellation specifically are Sesame and Push Health.
Who this pick isn't for
Hims is not the right pick if you're a first-time GLP-1 patient with significant medical complexity (multiple cardiovascular risk factors, recent pancreatitis history, complex medication interactions). The async-only review can't surface the kind of clinical context that a live visit catches. For complex first-timers, PlushCare's same-day video visit gives you the speed without the clinical thin-ness.
Hims is also not the right pick if your insurance covers GLP-1 and you want to maximize that coverage. Hims operates primarily as a cash-pay program with limited insurance billing. If your plan covers Wegovy or Zepbound with PA, PlushCare or Form Health save you more money over 12 months than Hims's fast cash-pay path, even with the longer 4 to 6 week PA timeline.
And Hims doesn't fit if you want a clinician who learns your case over time. Hims's async model produces a script reliably but doesn't build a clinician-patient relationship. Patients managing GLP-1 alongside other chronic conditions (T2D, hypertension, MASH) are better served by Knownwell, Form Health or a real PCP relationship that follows your full picture.
Runner-up: Ro Body
PlushCare is the runner-up specifically for patients who want to talk to a real PCP before paying. Same-day video visits, in-network with most commercial plans and PA can start within 24 hours of the visit.
Read the full Ro Body review →
Top 3 compared
| Program | Score | Starts from | Lock-in | Time to Rx |
|---|---|---|---|---|
| Hims & Hers | 7 | $298/mo | Month-to-month | 1 day |
| Ro Body | 7.5 | $373/mo | Month-to-month | 2 days |
Other strong picks
Frequently asked questions
What does '24 hours to prescription' actually mean?
Is the speed a clinical shortcut?
Can I get same-day medication if I'm desperate?
What if I'm in a hurry because my current medication runs out next week?
Do they ship overnight?
What if my first prescription gets denied or delayed?
Should I pay for the fast option if I'm not in a rush?
Sources
- FDA: Wegovy prescribing information and contraindications
- FDA: Zepbound (tirzepatide) prescribing information
- Federation of State Medical Boards: telehealth standards for prescribing controlled and non-controlled medications
Related
